3.5.4.B9	(12bS)-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine-10,11-diol	-	204483	
3.5.4.B9	(1R,2S)-2-(methylamino)-1-phenylpropan-1-ol	-	204497	
3.5.4.B9	(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoic acid	-	11723	
3.5.4.B9	(2S)-3-(3,4-dihydroxyphenyl)-2-hydrazinyl-2-methylpropanoic acid	-	204537	
3.5.4.B9	(3,4-dihydroxyphenyl)acetic acid	-	204573	
3.5.4.B9	(5E)-N-methyl-2,3-diphenyl-1,2,4-thiadiazol-5(2H)-imine	-	204680	
3.5.4.B9	(6aR)-6-(prop-2-en-1-yl)-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol	-	204688	
3.5.4.B9	(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol	-	204689	
3.5.4.B9	(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-2,10,11-triol	-	204690	
3.5.4.B9	(6aR)-6-propyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol	-	204691	
3.5.4.B9	(6R,7R)-3-[(acetyloxy)methyl]-8-oxo-7-[2-[(pyridin-4-yl)sulfanyl]acetamido]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid	-	204694	
3.5.4.B9	1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol	-	77163	
3.5.4.B9	2-amino-3-(2,4,5-trihydroxyphenyl)propanoic acid	-	204934	
3.5.4.B9	2-Iodoacetamide	-	7101	
3.5.4.B9	2-phenyl-1,2-benzoselenazol-3(2H)-one	-	204974	
3.5.4.B9	2-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-6-hydroxy-4H-pyran-4-one	-	204990	
3.5.4.B9	2-[methyl(nitroso)amino]benzene-1,4-diol	-	204993	
3.5.4.B9	3,3'-[(3-carboxy-4-oxocyclohexa-2,5-dien-1-yl)methanediyl]bis(6-hydroxybenzoic acid)	-	205011	
3.5.4.B9	3,5,7-trihydroxy-2-(3,4,5-trihydroxyphenyl)-4H-chromen-4-one	-	27098	
3.5.4.B9	4,4'-(2,3-dimethylbutane-1,4-diyl)dibenzene-1,2-diol	-	205109	
3.5.4.B9	4-(4,5,6,7-tetrahydrothieno[2,3-c]pyridin-4-yl)benzene-1,2-diol	-	205127	
3.5.4.B9	4-amino-5-methyl-1,2,4-triazole-3-thiol	-	89200	
3.5.4.B9	4-[(2-sulfanyl-1H-imidazol-1-yl)methyl]phenol	-	63170	
3.5.4.B9	4-[(4-bromobenzylidene)amino]-1,2,4-triazole-3-thiol	MN256.0105, 99% inhibition at 0.02 mM	89199	
3.5.4.B9	4-[(4-methoxybenzylidene)amino]-5-methyl-1,2,4-triazole-3-thiol	-	89201	
3.5.4.B9	4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,2-diol	-	190366	
3.5.4.B9	4-[methyl(nitroso)amino]benzene-1,2-diol	-	188840	
3.5.4.B9	6-amino-5,6,7,8-tetrahydronaphthalene-2,3-diol	-	205350	
3.5.4.B9	aurothio-beta-D-glucose	-	205398	
3.5.4.B9	benzene-1,4-diol	-	21363	
3.5.4.B9	cephapirin	-	4925	
3.5.4.B9	cyclohexa-2,5-diene-1,4-dione	-	205412	
3.5.4.B9	methyl 2-amino-3-(3,4-dihydroxyphenyl)propanoate	-	205455	
3.5.4.B9	additional information	not inhibited by 4-amino-1,2,4-triazol-3-ol, 4-amino-5-methyl-1,2,4-triazol-3-ol, 6-(4-methoxyphenyl)-3-methyl-1,2,4-triazolo[3,4-b]-[1,3,4]thiadiazole, and 3-(benzylthio)-5-methyl-1,2,4-triazol-4-amine	2	
3.5.4.B9	additional information	the virion infectivity factor of HIV binds cytoplasmic enzyme marking it for degradation	2	
3.5.4.B9	N-(3-thio-5-methyl-1,2,4-triazol-4-yl)benzamide	-	89202	
3.5.4.B9	N-[(4bS,8R,8aS)-7-(cyclopropylmethyl)-1,8a-dihydroxy-5,6,7,8,8a,9,14,14b-octahydro-4,8-methano[1]benzofuro[2,3-a]pyrido[4,3-b]carbazol-11-yl]guanidine	-	205713	
3.5.4.B9	N-[2-(3,4-dihydroxyphenyl)ethyl]acetamide	-	205739	
3.5.4.B9	p-chloromercuribenzoate	-	43	
3.5.4.B9	tetrasodium 3-[(E)-[4-formyl-5,6-dihydroxy-3-[(phosphonatoperoxy)methyl]pyridin-2-yl]diazenyl]-7-nitronaphthalene-1,5-disulfonate	-	205853